TipRanks
Go Ultimate55% OFF

Compare CytomX Therapeutics (6C1) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:6C1CytomX TherapeuticsCHF 420.06M-5.20―Strong BuyUnlock the CH:6C1 analyst price target with TipRanks PremiumCH:6C1Unlock the CH:6C1 top-analyst price target with TipRanks Premium
LXRXLexicon Pharmaceuticals$1.42$631.84M-9.445.97%Strong BuyUnlock the LXRX analyst price target with TipRanks PremiumCH:6C1 vs LXRXUnlock the LXRX top-analyst price target with TipRanks Premium
VSTMVerastem$9.75$1.18B-3.965.63%Strong BuyUnlock the VSTM analyst price target with TipRanks PremiumCH:6C1 vs VSTMUnlock the VSTM top-analyst price target with TipRanks Premium
ARCTArcturus Therapeutics$11.03$313.51M-3.3114.54%Strong BuyUnlock the ARCT analyst price target with TipRanks PremiumCH:6C1 vs ARCTUnlock the ARCT top-analyst price target with TipRanks Premium
BCYCBicycle Therapeutics$3.66$256.17M-1.80-58.22%NeutralUnlock the BCYC analyst price target with TipRanks PremiumCH:6C1 vs BCYCUnlock the BCYC top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:6C1CytomX Therapeutics―――
LXRXLexicon Pharmaceuticals1.420.064.41%
VSTMVerastem9.75-0.15-1.52%
ARCTArcturus Therapeutics11.031.7318.60%
BCYCBicycle Therapeutics3.66-3.60-49.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts